This unique new book uses a series of focussed questions, comprehensive literature evaluations and structured grades of recommendation to provide evidence for the treatment of hematological disorders, both malignant and benign. With contributions from leading international experts who have a real understanding of evidence-based medicine the book provides comprehensive reviews accompanied by clinical commentaries and recommendations on the best treatment regimes to adopt for individual patients. The book is split into two sections: the first examines the methodology underlying evidence based…mehr
This unique new book uses a series of focussed questions, comprehensive literature evaluations and structured grades of recommendation to provide evidence for the treatment of hematological disorders, both malignant and benign. With contributions from leading international experts who have a real understanding of evidence-based medicine the book provides comprehensive reviews accompanied by clinical commentaries and recommendations on the best treatment regimes to adopt for individual patients.
The book is split into two sections: the first examines the methodology underlying evidence based practice, and the second concentrates on the clinical practice of hematology, providing current "best evidence" to guide practice in a series of well-defined clinical situations.
This clinical reference is an invaluable source of evidence-based information distilled into guidance for clinical practice which will be welcomed by practitioners, trainees and associated health professionals.
Dr Mark Crowther is Associate Professor of Medicine and Program Director of the Adult Hematology Residency Training Program at McMaster University. He is a member of the Canadian Critical Care Trials Group. Dr. Jeffrey Ginsberg is a leading expert in the diagnosis, prevention and management of venous thromboembolism and has led many of the "practice changing" studies published in this area in the last 20 years. He is the recipient of numerous awards and distinctions, most recently an endowed chair at McMaster University allowing him to pursue further research in venous and arterial thrombosis. Dr. Holger Schünemann is a leading expert in evidence based practice with a particular interest in the development and widespread dissemination of validated evidence scoring criteria. Dr. Schünemann has played an important role in the evolution of evidence based guidelines currently written by organizations such as the American College of Chest Physicians and the American Thoracic Society. Dr. Ralph Meyer has recently joined the National Cancer Institute of Canada after a distinguished career at McMaster University. Dr. Meyer is responsible for administering the Clinical Trial Program at the NCIC. The NCIC has led or participated in many national and international studies which guide current best treatment practices for disorders such as Hodgkin's disease, multiple myeloma and other hematologic malignancies. Dr. Richard Lottenberg is a professor of medicine and past Division Chair of the division of Hematology and Oncology. He is currently the Training Program Director at the University of Florida and is widely regarded as an expert in the evidence based management of sickle cell anemia.
Inhaltsangabe
About the Contributors. Preface. Part I: A Guide to the Evidence. 1. Rating the quality of evidence and making recommendations 2. An overview of systematic reviews 3. Interpreting results of clinical research 4. Finding the evidence 5. Applying EBM in clinical practice 6. Using evidence to guide the diagnosis of disease Part II 7. Diagnosis of Deep Vein Thrombosis 8. Diagnosis of Pulmonary Embolism 9. Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism 10. Long-term Anticoagulation in Venous Thromboembolism 11. Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism 12. Inferior Vena Cava Interruption 13. Management of Venous Thromboembolism in Pregnancy 14. Pediatric Thrombosis 15. Bridging Anticoagulation in Patients who Require 16. Evidence-based approach to the diagnosis and management of thrombotic thrombocytopenic purpura 17. Diagnosis and Management of Disseminated Intravascular Coagulation 18. Diagnosis and Management of Hereditary Bleeding Disorders 19. Diagnosis and Management of Acquired Bleeding Disorders 20. Diagnosis and Management of Heparin-Induced Thrombocytopenia 21. Management of Antiphospholipid Antibody Syndrome Part III 22. Clinical Questions in iron overload 23. Aplastic Anemia 24. Acquired Anemias 25. Immune thrombocytopenic purpura 26. Neutropenia 27. Hypereosinophilia 28. Porphyrias 29. Membrane and Enzyme Abnormalities of the Erythrocyte 30. Sickle cell disease 31. Evidence-based treatment of thalassemia major Part IV 32. Acute Lymphoblastic Leukemia in Adults 33. Acute Myeloblastic Leukemia in Adults 34. Acute Myeloid Leukemia in Adults 35. Current Areas of Controversy in the Treatment of Patients 36. Chronic Lymphocytic Leukemia 37. Chronic Myelocytic Leukemia 38. Burkitt's Lymphoma 39. Primary Central Nervous System Lymphoma 40. Diffuse Large B-cell Lymphoma 41. Follicular Lymphoma 42. Lymphoblastic Lymphoma 43. Mantle Cell Lymphoma 44. Peripheral T-cell Lymphoma 45. Classical Hodgkin Lymphoma 46. Nodular Lymphocyte Predominant Hodgkin Lymphoma 47. Essential Thrombocythemia 48. Management of Patients with Polycythemia Vera 49. Multiple Myeloma 50. Waldenstroms Macroglobulinemia 51. Use of Hematopoietic Growth Factors for Hematologic Malignancies Index.
About the Contributors. Preface. Part I: A Guide to the Evidence. 1. Rating the quality of evidence and making recommendations 2. An overview of systematic reviews 3. Interpreting results of clinical research 4. Finding the evidence 5. Applying EBM in clinical practice 6. Using evidence to guide the diagnosis of disease Part II 7. Diagnosis of Deep Vein Thrombosis 8. Diagnosis of Pulmonary Embolism 9. Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism 10. Long-term Anticoagulation in Venous Thromboembolism 11. Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism 12. Inferior Vena Cava Interruption 13. Management of Venous Thromboembolism in Pregnancy 14. Pediatric Thrombosis 15. Bridging Anticoagulation in Patients who Require 16. Evidence-based approach to the diagnosis and management of thrombotic thrombocytopenic purpura 17. Diagnosis and Management of Disseminated Intravascular Coagulation 18. Diagnosis and Management of Hereditary Bleeding Disorders 19. Diagnosis and Management of Acquired Bleeding Disorders 20. Diagnosis and Management of Heparin-Induced Thrombocytopenia 21. Management of Antiphospholipid Antibody Syndrome Part III 22. Clinical Questions in iron overload 23. Aplastic Anemia 24. Acquired Anemias 25. Immune thrombocytopenic purpura 26. Neutropenia 27. Hypereosinophilia 28. Porphyrias 29. Membrane and Enzyme Abnormalities of the Erythrocyte 30. Sickle cell disease 31. Evidence-based treatment of thalassemia major Part IV 32. Acute Lymphoblastic Leukemia in Adults 33. Acute Myeloblastic Leukemia in Adults 34. Acute Myeloid Leukemia in Adults 35. Current Areas of Controversy in the Treatment of Patients 36. Chronic Lymphocytic Leukemia 37. Chronic Myelocytic Leukemia 38. Burkitt's Lymphoma 39. Primary Central Nervous System Lymphoma 40. Diffuse Large B-cell Lymphoma 41. Follicular Lymphoma 42. Lymphoblastic Lymphoma 43. Mantle Cell Lymphoma 44. Peripheral T-cell Lymphoma 45. Classical Hodgkin Lymphoma 46. Nodular Lymphocyte Predominant Hodgkin Lymphoma 47. Essential Thrombocythemia 48. Management of Patients with Polycythemia Vera 49. Multiple Myeloma 50. Waldenstroms Macroglobulinemia 51. Use of Hematopoietic Growth Factors for Hematologic Malignancies Index.
Rezensionen
"This book is an excellent collection of current best practices in hematology. It should appeal to all who have to deal with everyday challenges in blood diseases." (Journal of Tropical Pediatrics, June 2009)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
